BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15996600)

  • 1. The methylenetetrahydrofolate reductase C677T polymorphism does not associate with susceptibility to abdominal aortic aneurysm.
    Jones GT; Harris EL; Phillips LV; van Rij AM
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):137-42. PubMed ID: 15996600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele.
    Strauss E; Waliszewski K; Gabriel M; Zapalski S; Pawlak AL
    J Appl Genet; 2003; 44(1):85-93. PubMed ID: 12590185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase mutation in subjects with abdominal aortic aneurysm subdivided for age.
    Ferrara F; Novo S; Grimaudo S; Raimondi F; Meli F; Amato C; Amodeo G; Lo Presti R; Caimi G
    Clin Hemorheol Microcirc; 2006; 34(3):421-6. PubMed ID: 16614466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The normotensive carriers of the MTHFR 677T allele, displaying the increased risk of development of the abdominal aortic aneurysm (AAA), occur at the highest frequency among the smoking patients].
    Strauss E; Waliszewski K; Pawlak AL
    Przegl Lek; 2004; 61(10):1086-9. PubMed ID: 15794259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677-->T transition in the MTHFR gene.
    Zak I; Niemiec P; Sarecka B; Balcerzyk A; Ciemniewski Z; Rudowska E; Dylag S
    Acta Biochim Pol; 2003; 50(2):527-34. PubMed ID: 12833177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylenetetrahydrofolate reductase C677T-polymorphism and its association with alcohol withdrawal seizure.
    Lutz UC; Batra A; Kolb W; Machicao F; Maurer S; Köhnke MD
    Alcohol Clin Exp Res; 2006 Dec; 30(12):1966-71. PubMed ID: 17117960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.
    Yilmaz H; Isbir S; Agachan B; Ergen A; Farsak B; Isbir T
    Cell Biochem Funct; 2006; 24(1):87-90. PubMed ID: 15648053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.
    Pereira AC; Miyakawa AA; Lopes NH; Soares PR; de Oliveira SA; Cesar LA; Ramires JF; Hueb W; Krieger JE
    Thromb Res; 2007; 121(1):25-32. PubMed ID: 17604826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence of association between MTHFR C677T polymorphism and congenital heart disease in a TDT study design.
    Pereira AC; Xavier-Neto J; Mesquita SM; Mota GF; Lopes AA; Krieger JE
    Int J Cardiol; 2005 Oct; 105(1):15-8. PubMed ID: 16207540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
    Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
    Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of abdominal aortic aneurysms: a comprehensive meta-analysis involving eight candidate genes in over 16,700 patients.
    McColgan P; Peck GE; Greenhalgh RM; Sharma P
    Int Surg; 2009; 94(4):350-8. PubMed ID: 20302034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The different genotypes of MTHFR 1298A>C and PON1 -108C>T polymorphisms confer the increased risk of the abdominal aortic aneurysm in the smoking and nonsmoking persons].
    Strauss E; Waliszewski K; Pawlak AL
    Przegl Lek; 2005; 62(10):1023-30. PubMed ID: 16521945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study.
    Feng LG; Song ZW; Xin F; Hu J
    Psychiatry Res; 2009 Aug; 168(3):205-8. PubMed ID: 19564051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia.
    Al-Ali AK; Al-Muhana FA; Larbi EB; Abdulmohsen MF; Al-Sultan AI; Al-Maden MS; Al-Ateeq SA
    Saudi Med J; 2005 Dec; 26(12):1886-8. PubMed ID: 16380767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
    Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia.
    Roffman JL; Weiss AP; Purcell S; Caffalette CA; Freudenreich O; Henderson DC; Bottiglieri T; Wong DH; Halsted CH; Goff DC
    Biol Psychiatry; 2008 Jan; 63(1):42-8. PubMed ID: 17543893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.